Bacterial infections in kidney and kidney-pancreas transplant recipients

High incidence of multi-resistant microorganisms

  • Julio César Medina Universidad de la República, Facultad de Medicina, Cátedra de Enfermedades Infecciosas. Profesor Agregado
  • Virginia Antelo Universidad de la República, Facultad de Medicina, Cátedra de Enfermedades Infecciosas. Ex Residente, Especialista en Enfermedades Infecciosas
  • Marcelo Nin Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Cátedra de Nefrología, Trasplante. Profesor Agregado
  • Zaida Arteta Universidad de la República, Facultad de Medicina, Cátedra de Enfermedades Infecciosas, Parasitología. Profesor Adjunto
  • Francisco González Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Cátedra de Nefrología. Profesor
  • Cristina Bazet Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Departamento Laboratorio Clínico, Repartición Microbiología. Ex Profesora Agregada
  • Rossana Astesiano Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Cátedra de Nefrología. Asistente
  • Rossana Cordero Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Cátedra de Nefrología. Ex Asistente
  • Daniel López Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Área de Trasplantes. Coordinador quirúrgico y Profesor Agregado
  • Sergio Orihuela Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Programa de Trasplante Renal. Ex Director. Cátedra de Nefrología. Ex Profesor Agregado
Keywords: KIDNEY TRANSPLANTATION, PANCREAS TRANSPLANTATION, BACTERIAL INFECTIONS

Abstract

Introduction: bacterial infections in kidney (KTX) and kidney-pancreas transplant (KPTX) recipients are frequent and constitute one of the leading causes of death in this group of patients. The profile of these microorganisms needs to be identified in order to improve the empirical therapeutic approach.
Objective: to learn about the etiology and characteristics of both community and hospital-acquired bacterial infections in a group of patients who received KTX and KPTX, and were see at the Clinicas Hospital from November 1987 through November, 2010.
Method: retrospective study of the evolution of all patients with KTX and KPTX who were admitted at the Clinicas Hospital and presented at least one bacterial etiology infection episode, community and hospital-acquired. A multidrug-resistant (MDR) microorganism was defined if it were resistant to MRSA, VRE or a gram negative bacilli resistant to at least three groups of antimicrobial agents.
Results: during the period of study 122 patients received KTX or KPTX (six patients were transplanted in a center different form the Clinicas Hospital). Out of these patients, 64 (52.5%) developed at least one bacterial infection episode; 34 of them were women (53.1%), average age was 37.7± 11.4 years old. Thirty nine patients received KTX (60.1%) and 25 (39.1%) KPTX. Median follow up was five months (P25 = 1, P75 = 25). There were 138 bacterial infection episodes (2.07 episodes/patient), 76 of which were community acquired and 62 were hospital acquired. In both cases, the most frequent center of infection was the urinary system (63.2% and 53.2% respectively), followed respiratory infections in the community acquired infections (13%). E. coli was the predominant microorganism, followed by Klebsiella spp. and Enterococcus spp. Out of 103 microorganisms isolated, 46 (44.7%) evidenced multidrug-resistance - Klebsiella spp. and Acinetobacter baumannii being the most frequent agents).
Conclusions: the most frequent center of infection in community acquired infections were urinary and respiratory infections. As to hospital acquired infections, surgical lesions infections and urinary infections prevailed. E. coli and Klebsiella spp were the most frequent microorganisms in the community and Enterococcus spp., Klebsiella spp. and Acinetobacter baumannii were the most frequent one in the hospital context. A high prevalence of MO-MR was found in the first six months after transplantation, where A. baumannii appears as a problem pathogen given its high drug resistance.

References

(1) Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341(23):1725-30.
(2) Aguado JM, Gavaldà J, Garrido RS. Cronología y factores de riesgo de la infección en el paciente con trasplante de órgano sólido. In: Aguado JM, Fortún J, Gavaldà J, Pahissa A, De la Torre J, eds. Infecciones en pacientes trasplantados. 3a ed. Barcelona: Elsevier, 2009. p. 97-107.
(3) Alangaden GJ, Thyagarajan R, Gruber SA, Morawski K, Garnick J, El-Amm JM, et al. Infectious complications alter kidney transplantation current epidemiology and associeted risk factors. Clin Transplant 2006; 20(4):401-9.
(4) Valera B, Gentil MA, Cabello V, Fijo J, Cordero E, Cisneros JM. Epidemiology of urinary infections in renal transplant recipients. Transplant Proc 2006; 38(8):2414-5.
(5) Cervera C, Linares L, Perelló R, Marco F, Cofán F, Ricart MJ, et al. Cephalosporin resistant gram-negative bacilli infection (ESBL and AMPc) after kidney and kidney-pancreas transplant patients (abstract K-2674). En: Hooper DC, Hammer SM, Rothman-Denes LB, eds. Program and abstracts of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). American Society for Microbiology; 2006 Septiembre, San Francisco (CA), EUA; 2006. p. 350.
(6) Linares L, Cervera C, Cofán F, Ricart MJ, Esforzado N, Torregrosa V, et al. Epidemiology and outcomes of multiple antibiotic-resistance bacterial infection in renal transplantation. Transplant Proc 2007; 39(7):2222-4.
(7) Garzoni C; AST Infectious Diseases Community of Practice. Multiply resistant gram-positive bacteria methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus (MRSA, VISA, VRSA) in solid organ transplant recipients. Am J Transplant 2009; 9(Suppl 4):S41-9.
(8) Van Delden C, Blumberg EA; AST Infectious Diseases Community of Practice. Multidrug resistant gram-negative bacteria in solid organ transplant recipients. Am J Transplant 2009; 9(Suppl 4):S27-34.
(9) Zárate MS, Gales AC, Picão RC, Pujol GS, Lanza A, Smayevsky J. Outbreak of OXY-2-Producing Klebsiella oxytoca in a renal transplant unit. J Clin Microbiol 2008; 46(6):2099-101.
(10) Martins IS, Moreira BM, Riley LW, Santoro-Lopes G. Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection among renal transplant recipients. J Hosp Infect 2006; 64(3):305-8.
(11) Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007; 13(1):97-103.
(12) Wareham DW, Bean DC, Khanna P, Hennessy EM, Krahe D, Ely A, et al. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors, and impact of multidrug resistance. Eur J Clin Microbiol Infect Dis 2008; 27(7):607-12.
(13) Reik R, Tenover FC, Klein E, McDonald LC. The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. Diagn Microbiol Infect Dis 2008; 62(1):81-5.
(14) Mynarczyk G, Grzybowska W, M³ynarczyk A, Tyski S, Kawecki D, £uczak M, et al. Occurrence of glycopeptide-resistant enterococci in transplant medicine internal wards in 2001-2005. Transplant Proc 2007; 39(9):2886-9.
(15) Muñoz P, AST Infectious Diseases Community of Practice. Multiply resistant gram-positive bacteria: vancomycin-resistant enterococcus in solid organ transplant recipients. Am J Transplant 2009; 9(Suppl 4):S50-6.
(16) Freitas MC, Pacheco-Silva A, Barbosa D, Silbert S, Sader H, Sesso R, et al. Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients. BMC Infect Dis 2006; 6: 133.
(17) Russell DL, Flood A, Zaroda TE, Acosta C, Riley MM, Busuttil RW, et al. Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant 2008; 8(8):1737-43.
(18) Patel R, Allen SL, Manahan JM, Wright AJ, Krom RA, Wiesner RH, et al. Natural history of vancomycin resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl 2001; 7(1):27-31.
(19) Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357(25):2601-14.
(20) Trilla A, Barrio JL. Enfermedades infecciosas, infecciones nosocomiales. En: Rozman C, Farreras P, eds. Tratado de Medicina Interna. Barcelona: Doyma, 1996. p. 2553-9.
(21) Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 2008; 13(47):19045.
(22) Splendiani G, Cipriani S, Tisone G, Iorio B, Condo S, Vega A, et al. Infectious complications in renal transplant recipients. Transplant Proc 2005; 37(6):2497-9.
(23) Sousa SR, Galante NZ, Barbosa DA, Pestana JO. Incidência e fatores de risco para complicações infecciosas no primeiro ano após o transplante renal. J Bras Nefrol 2010; 32(1):75-82.
(24) Chuang P, Parikh CR, Langone A. Urinary tract infections after renal transplantation: a retrospective at two US transplant centers. Clin Transplant 2005; 19(2):230-5.
(25) Grimaldi A, Barletta A, Rascente M, Pisani F, Iaria G, Maccarone D, et al. Infectious complications in the renal transplant recipient. Transplant Proc 2005; 37(6):2502-3.
(26) Audard V, Amor M, Desvaux D, Pastural M, Baron C, Philippe R, et al. Acute graft pyelonephritis: a potential cause of acute rejection in renal transplant. Transplantation 2005; 80(8):1128-30.
(27) Kamath NS, John GT, Neelakantan N, Kirubakaran MG, Jacob CK. Acute graft pyelonephritis following renal transplantation. Transpl Infect Dis 2006; 8(3):140-7.
(28) hosroshahi HT, Mogaddam AN, Shoja MM. Efficacy of high-dose trimethroprim-sulfamethoxazol prophilaxis on early urinary tract infection after renal transplantation. Transplant Proc 2006; 38(7):2062-4.
(29) García-Prado ME, Cordero E, Cabello V, Pereira P, Torrubia FJ, Ruiz M, et al. Complicaciones infecciosas en 159 receptores de trasplante renal consecutivos. Enferm Infecc Microbiol Clin 2009; 27(1):22-7.
(30) Reddy P, Zembower TR, Ison MG, Baker TA, Stosor V. Carbapenem reisistant Acinetobacter baumannii infections after organ transplantation. Transplant Infectious Disease 2010; 12(1):87-93.
(31) Kuo LC, Lai CC, Liao CH, Hsu CK, Chang YL, Chang CY, et al. Multidrug-resistant Acinetobacter baumannii bacteremia: clinical features, antimicrobial therapy and outcome. Clin Microbiol Infect 2007; 13(2):196-8.
(32) Romanelli RM, Clemente WT, Lima SS, Rezende EM, Martinho GH, Paiva LF, et al. MRSA outbreak at a transplantation unit. Braz Infect Dis 2010; 14(1):54-9.
(33) McNeil SA, Malani PN, Chenoweth CE, Fontana RJ, Magee JC, Punch JD, et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis 2006; 42(2):195-203.
Published
2012-09-30
How to Cite
1.
Medina JC, Antelo V, Nin M, Arteta Z, González F, Bazet C, Astesiano R, Cordero R, López D, Orihuela S. Bacterial infections in kidney and kidney-pancreas transplant recipients. Rev. Méd. Urug. [Internet]. 2012Sep.30 [cited 2024Dec.18];28(3):190-8. Available from: https://www2.rmu.org.uy/ojsrmu311/index.php/rmu/article/view/339
Issue
Vol 28 No 3 (2012): Revista Médica del Uruguay
Section
Original Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.